Effects of Vitamin D supplementation on resolution of fever and cough in children with pulmonary tuberculosis: A randomized double-blind controlled trial in Indonesia

Lianda Tamara, Cissy B Kartasasmita, Anggraini Alam, Dida A Gurnida, Lianda Tamara, Cissy B Kartasasmita, Anggraini Alam, Dida A Gurnida

Abstract

Background: Various studies in adults have shown a strong association between vitamin D and tuberculosis (TB), both in terms of vitamin D status and the benefits of vitamin D in managing TB. Studies on vitamin D and its relationship with childhood TB still lack in Indonesia as a country with the second-highest TB incidence globally. This study evaluated the effect of vitamin D supplementation on resolution of cough and fever in Indonesian children with pulmonary TB.

Methods: We conducted a randomized controlled trial of vitamin D supplementation in children with pulmonary TB and vitamin D insufficiency. Patients were randomly allocated with 1:1 ratio to receive either 1000 IU vitamin D or placebo daily after starting standard TB treatment. The primary outcome in this study was the resolution of fever and cough symptoms reviewed weekly after starting the treatment until the symptoms are resolved. The secondary outcome in this study was 25-hydroxyvitamin D serum level and nutritional status which was reviewed at the end of the trial. Intention to treat analyses were applied. Differences in clinical outcomes between two groups were calculated using Mann-Whitney U test or χ2 test, where appropriate.

Findings: A total of 84 patients met the inclusion criteria, aged 6 to 18 years old, newly diagnosed with pulmonary TB and vitamin D insufficiency. Eighty patients (95,2%) completed the six months follow-up. Faster resolution of fever, cough, improved malnutrition status, and higher vitamin D level were found in the intervention group compared to the placebo group (all P < 0.001).

Conclusions: Vitamin D is beneficial in improving fever and cough resolution, and improving nutritional status in children with pulmonary TB and vitamin D insufficiency. Determination of adequate supplementation levels of more than 1000 IU requires further research to achieve normal vitamin D levels during the duration of treatment for pulmonary TB in children.

Trial registration: ClinicalTrials.gov (NCT05073965).

Conflict of interest statement

Competing interests: The authors completed the ICMJE Unified Competing Interest Form (available upon request from the corresponding author), and declare no conflicts of interest.

Copyright © 2022 by the Journal of Global Health. All rights reserved.

Figures

Figure 1
Figure 1
Flowchart of the exclusion process. ADIH – antituberculosis drug-induced hepatotoxicity, HIV – human immunodeficiency virus

References

    1. World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020.
    1. Jenkins HE.Global burden of childhood tuberculosis. Pneumonia. 2016;8:1-7. 10.1186/s41479-016-0018-6
    1. Sarin P, Duffy J, Mughal Z, Hedayat E, Manaseki-Holland S.Vitamin D and tuberculosis: review and association in three rural provinces of Afghanistan. Int J Tuberc Lung Dis. 2016;20:383-8. 10.5588/ijtld.15.0303
    1. Wang J, Feng M, Ying S, Zhou J, Li X.Efficacy and Safety of Vitamin D Supplementation for Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Iran J Public Health. 2018;47:466-72.
    1. Wu HX, Xiong X, Zhu M, Wei J, Zhuo K, Cheng D.Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med. 2018;18:108. 10.1186/s12890-018-0677-6
    1. Aibana O, Huang CC, Aboud S, Arnedo-Pena A, Becerra MC, Bellido-Blasco JB, et al. Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual participant data meta-analysis. PLoS Med. 2019;16:e1002907. 10.1371/journal.pmed.1002907
    1. Gou X, Pan L, Tang F, Gao H, Xiao D.The association between Vitamin D status and tuberculosis in children: A meta-analysis. Medicine (Baltimore). 2018;97:e12179. 10.1097/MD.0000000000012179
    1. Huang S-J, Wang X, Liu Z-D, Cao W-L, Han Y, Ma A-G, et al. Vitamin D deficiency and the risk of tuberculosis: a meta-analysis. Drug Des Devel Ther. 2016;11:91-102. 10.2147/DDDT.S79870
    1. Soeharto DA, Rifai DA, Marsudidjadja S, Roekman AE, Assegaf CK, Louisa M.Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report. Adv Prev Med. 2019;2019:5181847. 10.1155/2019/5181847
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-30. 10.1210/jc.2011-0385
    1. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007;176:208-13. 10.1164/rccm.200701-007OC
    1. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet. 2011;377:242-50. 10.1016/S0140-6736(10)61889-2
    1. Nursyam EW, Amin Z, Rumende CM.The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38:3-5.
    1. Finklea JD, Grossmann RE, Tangpricha V.Vitamin D and chronic lung disease: A review of molecular mechanisms and clinical studies. Adv Nutr. 2011;2:244-53. 10.3945/an.111.000398
    1. Naik AL.Effect of DOTS Treatment on Vitamin D Levels in Pulmonary Tuberculosis. J Clin Diagn Res. 2017;11:BC18-22. 10.7860/JCDR/2017/24501.9759
    1. Venturini E, Facchini L, Martinez-Alier N, Novelli V, Galli L, de Martino M, et al. Vitamin D and tuberculosis: A multicenter study in children. BMC Infect Dis. 2014;14:652. 10.1186/s12879-014-0652-7
    1. Battersby AJ, Kampmann B, Burl S.Vitamin D in early childhood and the effect on immunity to mycobacterium tuberculosis. Clin Dev Immunol. 2012. 10.1155/2012/430972
    1. Ganmaa D, Giovannucci E, Bloom BR, Fawzi W, Burr W, Batbaatar D, et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: A randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr. 2012;96:391-6. 10.3945/ajcn.112.034967
    1. Morcos MM, Gabr AA, Samuel S, Kamel M, el Baz M, el Beshry MMR.Vitamin D administration to tuberculous children and its value. Boll Chim Farm. 1998;137:157-64.
    1. Mehta S, Mugusi FM, Bosch RJ, Aboud S, Chatterjee A, Finkelstein JL, et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. Nutr J. 2011;10:120. 10.1186/1475-2891-10-120
    1. Yani FF, Lipoeto NI, Supriyatno B, Darwin E, Basir D.Vitamin D status in under-five children with a history of close tuberculosis contact in Padang, West Sumatra. Asia Pac J Clin Nutr. 2017;26:S68-72.
    1. Triasih R, Graham SM.Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation. Paediatr Indones. 2011;51:332-7. 10.14238/pi51.6.2011.332-7
    1. Thomas TA.Tuberculosis in children. Pediatr Clin North Am. 2017;64:893-909. 10.1016/j.pcl.2017.03.010
    1. Mpofu N, Moyo S, Mulenga H, Luabeya KKA, Tameris M, Geldenhuys H, et al. Time to symptom resolution in young children treated for pulmonary tuberculosis. Pediatr Infect Dis J. 2014;33:1226-30. 10.1097/INF.0000000000000523
    1. Yassin Z, Ahmadinejad Z.The Fever Response after Treatment of Tuberculosis: What is the Expected Time and What are the Risk Factors? J Infec Dis Treat. 2016;2:1-4. 10.21767/2472-1093.100011
    1. Marais BJ, Gie RP, Obihara CC, Hesseling AC, Schaaf HS, Beyers N.Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child. 2005;90:1162-5. 10.1136/adc.2004.070797
    1. Fabbri A, Infante M, Ricordi C.Vitamin D status: a key modulator of innate immunity and natural defense from acute viral respiratory infections. Eur Rev Med Pharmacol Sci. 2020;24:4048-52.
    1. Jolliffe DA, Camargo CA, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9:276-92. 10.1016/S2213-8587(21)00051-6
    1. Aggarwal AN.Quality of life with tuberculosis. J Clin Tuberc Other Mycobact Dis. 2019;17:100121. 10.1016/j.jctube.2019.100121
    1. Blankenship JL, Rudert C, Aguayo VM.Triple trouble: Understanding the burden of child undernutrition, micronutrient deficiencies, and overweight in East Asia and the Pacific. Matern Child Nutr. 2020;16:e12950. 10.1111/mcn.12950
    1. Carvalho ACC, Cardoso CAA, Martire TM, Migliori GB, Sant’Anna CC.Epidemiological aspects, clinical manifestations, and prevention of pediatric tuberculosis from the perspective of the End TB strategy. J Bras Pneumol. 2018;44:134-44. 10.1590/s1806-37562017000000461
    1. Saraswati LD, Ginandjar P, Widjanarko B, Puspitasari RA.Epidemiology of Child Tuberculosis (A Cross-Sectional Study at Pulmonary Health Center Semarang City, Indonesia). IOP Conf Ser Earth Environ Sci. 2018;116:012081. 10.1088/1755-1315/116/1/012081
    1. Sheng L, Xue Y, He X, Zhu Y, Li H, Wu Y, et al. Effects of repeated administration of rifampicin and isoniazid on vitamin D metabolism in mice. Steroids. 2015;104:203-7. 10.1016/j.steroids.2015.10.004
    1. Rey C, Sáncheza-Arango D, Lópeza-Herce J, Martíneza-Camblor P, Garcíaa-Hernández I, Prieto B, et al. Vitamin D deficiency at pediatric intensive care admission. J Pediatr (Rio J). 2014;90:135-42. 10.1016/j.jped.2013.08.004

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi